261 related articles for article (PubMed ID: 28670979)
21. Inhibition of KIF14 Suppresses Tumor Cell Growth and Promotes Apoptosis in Human Glioblastoma.
Huang W; Wang J; Zhang D; Chen W; Hou L; Wu X; Lu Y
Cell Physiol Biochem; 2015; 37(5):1659-70. PubMed ID: 26536004
[TBL] [Abstract][Full Text] [Related]
22. SiRNA knockdown of the DEK nuclear protein mRNA enhances apoptosis and chemosensitivity of canine transitional cell carcinoma cells.
Yamazaki H; Iwano T; Otsuka S; Kagawa Y; Hoshino Y; Hosoya K; Okumura M; Takagi S
Vet J; 2015 Apr; 204(1):60-5. PubMed ID: 25773167
[TBL] [Abstract][Full Text] [Related]
23. Axin induces cell death and reduces cell proliferation in astrocytoma by activating the p53 pathway.
Zhang LY; Ye J; Zhang F; Li FF; Li H; Gu Y; Liu F; Chen GS; Li Q
Int J Oncol; 2009 Jul; 35(1):25-32. PubMed ID: 19513548
[TBL] [Abstract][Full Text] [Related]
24. Immunoexpression of tumor suppressor genes p53, p21 WAF1/CIP1 and p27 KIP1 in humam astrocystic tumors.
Faria MH; Patrocínio RM; Moraes Filho MO; Rabenhorst SH
Arq Neuropsiquiatr; 2007 Dec; 65(4B):1114-22. PubMed ID: 18345413
[TBL] [Abstract][Full Text] [Related]
25. siRNA-mediated knockdown of JUB expression suppresses the proliferation of glioblastoma cells.
Ouyang H; Guo Z; Cheng Z; Guo Y
Cancer Biomark; 2015; 15(4):477-84. PubMed ID: 26406867
[TBL] [Abstract][Full Text] [Related]
26. Caspase-dependent apoptosis induction by targeted expression of DEK in Drosophila involves histone acetylation inhibition.
Lee KS; Kim DW; Kim JY; Choo JK; Yu K; Seo SB
J Cell Biochem; 2008 Mar; 103(4):1283-93. PubMed ID: 17685435
[TBL] [Abstract][Full Text] [Related]
27. B-cell CLL/lymphoma 3 promotes glioma cell proliferation and inhibits apoptosis through the oncogenic STAT3 pathway.
Wu J; Li L; Jiang G; Zhan H; Wang N
Int J Oncol; 2016 Dec; 49(6):2471-2479. PubMed ID: 27748795
[TBL] [Abstract][Full Text] [Related]
28. Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors.
Cai J; Chen J; Zhang W; Yang P; Zhang C; Li M; Yao K; Wang H; Li Q; Jiang C; Jiang T
Oncotarget; 2015 Jul; 6(20):18105-15. PubMed ID: 25971279
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators.
Cerda SR; Mustafi R; Little H; Cohen G; Khare S; Moore C; Majumder P; Bissonnette M
Oncogene; 2006 May; 25(22):3123-38. PubMed ID: 16434969
[TBL] [Abstract][Full Text] [Related]
30. ALEX1 Regulates Proliferation and Apoptosis in Breast Cancer Cells.
Gao Y; Wu JY; Zeng F; Liu GL; Zhang HT; Yun H; Song FZ
Asian Pac J Cancer Prev; 2015; 16(8):3293-9. PubMed ID: 25921134
[TBL] [Abstract][Full Text] [Related]
31. Regulation of DEK expression by AP-2α and methylation level of DEK promoter in hepatocellular carcinoma.
Qiao MX; Li C; Zhang AQ; Hou LL; Yang J; Hu HG
Oncol Rep; 2016 Oct; 36(4):2382-90. PubMed ID: 27499261
[TBL] [Abstract][Full Text] [Related]
32. Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors.
Bian XW; Shi JQ; Liu FX
Anal Quant Cytol Histol; 2000 Dec; 22(6):429-37. PubMed ID: 11147296
[TBL] [Abstract][Full Text] [Related]
33. Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells.
Lin H; Xiong W; Zhang X; Liu B; Zhang W; Zhang Y; Cheng J; Huang H
Oncol Rep; 2011 Oct; 26(4):925-30. PubMed ID: 21743969
[TBL] [Abstract][Full Text] [Related]
34. The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7.
Wise-Draper TM; Allen HV; Thobe MN; Jones EE; Habash KB; Münger K; Wells SI
J Virol; 2005 Nov; 79(22):14309-17. PubMed ID: 16254365
[TBL] [Abstract][Full Text] [Related]
35. The involvement of cellular proliferation status in the expression of the human proto-oncogene DEK.
Ageberg M; Gullberg U; Lindmark A
Haematologica; 2006 Feb; 91(2):268-9. PubMed ID: 16461319
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of Pim-3 suppresses the tumorigenicity of glioblastoma by regulating cell cycle and apoptosis.
Quan J; Zhou L; Qu J
Cell Mol Biol (Noisy-le-grand); 2015 Mar; 61(1):42-50. PubMed ID: 25817345
[TBL] [Abstract][Full Text] [Related]
37. The DEK oncoprotein and its emerging roles in gene regulation.
Sandén C; Gullberg U
Leukemia; 2015 Aug; 29(8):1632-6. PubMed ID: 25765544
[TBL] [Abstract][Full Text] [Related]
38. DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.
Martinez-Useros J; Rodriguez-Remirez M; Borrero-Palacios A; Moreno I; Cebrian A; Gomez del Pulgar T; del Puerto-Nevado L; Vega-Bravo R; Puime-Otin A; Perez N; Zazo S; Senin C; Fernandez-Aceñero MJ; Soengas MS; Rojo F; Garcia-Foncillas J
BMC Cancer; 2014 Dec; 14():965. PubMed ID: 25515240
[TBL] [Abstract][Full Text] [Related]
39. Silencing of Bmi-1 gene enhances chemotherapy sensitivity in human glioblastoma cells.
Hong Y; Shang C; Xue YX; Liu YH
Med Sci Monit; 2015 Apr; 21():1002-7. PubMed ID: 25858624
[TBL] [Abstract][Full Text] [Related]
40. p53-dependent regulation of Mcl-1 contributes to synergistic cell death by ionizing radiation and the Bcl-2/Bcl-XL inhibitor ABT-737.
Tagscherer KE; Fassl A; Sinkovic T; Combs SE; Roth W
Apoptosis; 2012 Feb; 17(2):187-99. PubMed ID: 22002102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
